Mitochondrial antibiograms in personalized medicine

Human Molecular Genetics

Volumn 22, Issue 6, 2013, Pages 1132-1139

  Pacheu Grau, David ^a,b   Gómez Durán, Aurora ^a,b   Iglesias, Eldris ^a,b   Ló pez Gallardo, Ester ^a,b   Montoya, Julio ^a,b   Ruiz Pesini, Eduardo ^a,b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; LINEZOLID; MITOCHONDRIAL DNA; OXIDOREDUCTASE; PAROMOMYCIN; RIBOSOME RNA; RNA 16S; SUCCINATE DEHYDROGENASE;

ALLELE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYBRID; DNA POLYMORPHISM; DRUG BINDING; DRUG BLOOD LEVEL; ELECTRON TRANSPORT; HAPLOTYPE; HUMAN; HUMAN CELL; INTERACTIONS WITH DNA; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL ANTIBIOGRAM; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXYGEN CONSUMPTION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RESPIRATORY CHAIN; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CELL LINE; HUMANS; INDIVIDUALIZED MEDICINE; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS;

EID: 84874541478     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds517     Document Type: Article

References (40)

1. Lazarou, J., Pomeranz, B.H. and Corey, P.N. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA, 279, 1200-1205.
2. Bottger, E.C. (2007) Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity-lessons to be learned. Cell. Mol. Life Sci., 64, 791-795.
3. Bottger, E.C., Springer, B., Prammananan, T., Kidan, Y. and Sander, P. (2001) Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep., 2, 318-323.
4. Yonath, A. (2005) Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. Annu. Rev. Biochem., 74, 649-679.
5. Pacheu-Grau, D., Gomez-Duran, A., Lopez-Perez, M.J., Montoya, J. and Ruiz-Pesini, E. (2010) Mitochondrial pharmacogenomics: barcode for antibiotic therapy. Drug Discov. Today, 15, 33-39.
6. Pacheu-Grau, D., Gomez-Duran, A., Montoya, J. and Ruiz-Pesini, E. (2010) Influence of mtDNA genetic variation on antibiotic therapy. Pharmacogenomics, 11, 1185-1187.
7. Bottger, E.C. (2010) Mutant A1555G mitochondrial 12S rRNA and aminoglycoside susceptibility. Antimicrob. Agents Chemother., 54, 3073- 3074. author reply 3074-3075.
8. Pacheu-Grau, D., Gomez-Duran, A., Lopez-Gallardo, E., Pinos, T., Andreu, A.L., Lopez-Perez, M.J., Montoya, J. and Ruiz-Pesini, E. (2011) 'Progress' renders detrimental an ancient mitochondrial DNA genetic variant. Hum. Mol. Genet., 20, 4224-4231.
9. Montoya, J., Lopez-Gallardo, E., Diez-Sanchez, C., Lopez-Perez, M.J. and Ruiz-Pesini, E. (2009) 20 years of human mtDNA pathologic point mutations: carefully reading the pathogenicity criteria. Biochim. Biophys. Acta, 1787, 476-483.
10. Ruiz-Pesini, E. and Wallace, D.C. (2006) Evidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNA. Hum. Mutat., 27, 1072-1081.
11. Gould, F.K. (2011) Linezolid: safety and efficacy in special populations. J. Antimicrob. Chemother., 66(Suppl 4), iv3-iv6.
12. Sciotti, R.J., Pliushchev, M., Wiedeman, P.E., Balli, D., Flamm, R., Nilius, A.M., Marsh, K., Stolarik, D., Jolly, R., Ulrich, R. et al. (2002) The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. Bioorg. Med. Chem. Lett., 12, 2121-2123.
13. Nagiec, E.E., Wu, L., Swaney, S.M., Chosay, J.G., Ross, D.E., Brieland, J.K. and Leach, K.L. (2005) Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. Antimicrob. Agents Chemother., 49, 3896-3902.
14. Soriano, A., Miro, O. and Mensa, J. (2005) Mitochondrial toxicity associated with linezolid. N. Engl. J. Med., 353, 2305-2306.
15. De Vriese, A.S., Coster, R.V., Smet, J., Seneca, S., Lovering, A., Van Haute, L.L., Vanopdenbosch, L.J., Martin, J.J., Groote, C.C., Vandecasteele, S. et al. (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clin. Infect. Dis., 42, 1111-1117.
16. McKee, E.E., Ferguson, M., Bentley, A.T. and Marks, T.A. (2006) Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother., 50, 2042-2049.
17. Garrabou, G., Soriano, A., Lopez, S., Guallar, J.P., Giralt, M., Villarroya, F., Martinez, J.A., Casademont, J., Cardellach, F., Mensa, J. et al. (2007) Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob. Agents Chemother., 51, 962-967.
18. Palenzuela, L., Hahn, N.M., Nelson, R.P. Jr., Arno, J.N., Schobert, C., Bethel, R., Ostrowski, L.A., Sharma, M.R., Datta, P.P., Agrawal, R.K. et al. (2005) Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?. Clin. Infect. Dis., 40, e113-e116.
19. Carson, J., Cerda, J., Chae, J.H., Hirano, M. and Maggiore, P. (2007) Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism. Pharmacotherapy, 27, 771- 774.
20. Dryden, M.S. (2011) Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J. Antimicrob. Chemother., 66(Suppl 4), iv7-iv15.
21. Moreno-Loshuertos, R., Ferrin, G., Acin-Perez, R., Gallardo, M.E., Viscomi, C., Perez-Martos, A., Zeviani, M., Fernandez-Silva, P. and Enriquez, J.A. (2011) Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations. PLoS Genet., 7, e1001379.
22. Guan, M.X., Fischel-Ghodsian, N. and Attardi, G. (2000) A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum. Mol. Genet., 9, 1787-1793.
23. Balbi, H.J. (2004) Chloramphenicol: a review. Pediatr. Rev., 25, 284- 288.
24. Blanc, H., Adams, C.W. and Wallace, D.C. (1981) Different nucleotide changes in the large rRNA gene of the mitochondrial DNA confer chloramphenicol resistance on two human cell lines. Nucleic Acids Res., 9, 5785-5795.
25. Kearsey, S.E. and Craig, I.W. (1981) Altered ribosomal RNA genes in mitochondria from mammalian cells with chloramphenicol resistance. Nature, 290, 607-608.
26. King, M.P. and Attardi, G. (1988) Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell, 52, 811-819.
27. Prezant, T.R., Agapian, J.V., Bohlman, M.C., Bu, X., Oztas, S., Qiu, W.Q., Arnos, K.S., Cortopassi, G.A., Jaber, L., Rotter, J.I. et al. (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet., 4, 289-294.
28. Zhao, H., Li, R., Wang, Q., Yan, Q., Deng, J.H., Han, D., Bai, Y., Young, W.Y. and Guan, M.X. (2004) Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am. J. Hum. Genet., 74, 139-152.
29. Rodriguez-Ballesteros, M., Olarte, M., Aguirre, L.A., Galan, F., Galan, R., Vallejo, L.A., Navas, C., Villamar, M., Moreno-Pelayo, M.A., Moreno, F. et al. (2006) Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C-.T mutation in the mitochondrial 12S rRNA gene. J. Med. Genet., 43, e54.
30. Zhu, Y., Li, Q., Chen, Z., Kun, Y., Liu, L., Liu, X., Yuan, H., Zhai, S., Han, D. and Dai, P. (2009) Mitochondrial haplotype and phenotype of 13 Chinese families may suggest multi-original evolution of mitochondrial C1494T mutation. Mitochondrion, 9, 418-428.
31. Bitner-Glindzicz, M., Pembrey, M., Duncan, A., Heron, J., Ring, S.M., Hall, A. and Rahman, S. (2009) Prevalence of mitochondrial 1555A-.G mutation in European children. N. Engl. J. Med., 360, 640-642.
32. Vandebona, H., Mitchell, P., Manwaring, N., Griffiths, K., Gopinath, B., Wang, J.J. and Sue, C.M. (2009) Prevalence of mitochondrial 1555A-.G mutation in adults of European descent. N. Engl. J. Med., 360, 642-644.
33. Zhang, Z., Ding, W., Liu, X., Xu, B., Du, W., Nan, S. and Guo, Y. (2012) Auditory screening concurrent deafness predisposing genes screening in 10,043 neonates in Gansu province, China. Int. J. Pediatr. Otorhinolaryngol., 76, 984-988.
34. Zhang, A.M., Jia, X., Bi, R., Salas, A., Li, S., Xiao, X., Wang, P., Guo, X., Kong, Q.P., Zhang, Q. et al. (2011) Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients. PLoS One, 6, e27750.
35. Cerezo, M., Cerny, V., Carracedo, A. and Salas, A. (2011) New insights into the Lake Chad Basin population structure revealed by high-throughput genotyping of mitochondrial DNA coding SNPs. PLoS One, 6, e18682.
36. King, M.P. and Attardi, G. (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science, 246, 500-503.
37. Chomyn, A., Lai, S.T., Shakeley, R., Bresolin, N., Scarlato, G. and Attardi, G. (1994) Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals-and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet., 54, 966-974.
38. Gomez-Duran, A., Pacheu-Grau, D., Lopez-Gallardo, E., Diez-Sanchez, C., Montoya, J., Lopez-Perez, M.J. and Ruiz-Pesini, E. (2010) Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet., 19, 3343-3353.
39. Gomez-Duran, A., Pacheu-Grau, D., Martinez-Romero, I., Lopez-Gallardo, E., Lopez-Perez, M.J., Montoya, J. and Ruiz-Pesini, E. (2012) Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Biochim. Biophys. Acta., 1822, 1216-1222.
40. Lorente, L., Martin, M.M., Lopez-Gallardo, E., Iceta, R., Sole-Violan, J., Blanquer, J., Labarta, L., Diaz, C., Jimenez, A., Lafuente, N. et al. (2011) Platelet cytochrome c oxidase activity and quantity in septic patients. Crit. Care Med., 39, 1289-1294.